Upbound Group UPBD 深 沪
已收盘 11-13 16:00:00 美东时间
25.09
+1.210
+5.07%
华盛通- 最 高25.12
- 今 开23.83
- 成交量 175.75万股
- 最 低 23.60
- 昨 收 23.88
- 总市值 146.28万
- 52周最高 25.52
- 市盈率 静 20.08
- 换手率 3014.52%
- 52周最低 14.74
- 委 比 -70.18%
- 总股本 5.83万
- 历史最高 60.13
- 量 比 1.21
- 振 幅 6.37%
- 历史最低 -2.75
- 每 手 1
- 风险率 1.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alpha Buying: Follow the CFOs Into 5 Stocks Worth Watching
Wall Street has an endless supply of people willing to tell you which stocks to buy. They have price targets, elaborate presentations, and enough confidence to make you wonder why they still need a salary. I would rather know what the chief financial officer is buying. When the person responsible fo...
11-13 00:40
Top 3 Consumer Stocks That May Fall Off A Cliff This month
As of Nov. 11, 2026, three stocks in the consumer discretionary sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days w...
11-11 21:47
美股大行评级 | 潜在涨幅332.55%！Viking Therapeutics获上调目标价至118美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至118美元；Canaccord Genuity：维持Aclaris Therapeutics"买入"评级，目标价从10美元升至13美元
11-02 18:53
Upbound Group shares are trading higher after the company reported better-than-expected Q3 financial results.
Upbound Group shares are trading higher after the company reported better-than-expected Q3 financial results.
10-29 22:22
Upbound Group Sees Q4 Adj EPS $1.00-$1.10 vs $1.10 Est; Sees Sales $1.150B-$1.250B vs $1.226B Est
Upbound Group (NASDAQ:UPBD) is looking for Q4 Adj EPS of $1.00-$1.10 vs $1.10 analyst estimate. sees sales of $1.150 billion-$1.250 billion vs $1.226 billion analyst estimate.
10-29 19:03
Upbound Group Narrows FY2026 Adj EPS Guidance from $4.00-$4.35 to $4.15-$4.30 vs $4.16 Est; Lowers FY2026 Sales Guidance from $4.700B-$4.850B to $4.680B-$4.780B vs $4.733B Est
Upbound Group (NASDAQ:UPBD) narrows FY2026 Adj EPS guidance from $4.00-$4.35 to $4.15-$4.30 vs $4.16 analyst estimate. Lowers FY2026 sales outlook from $4.700 billion-$4.850 billion to $4.680 billion-$4.780 billion vs $4.733 billion estimate.
10-29 19:02
美股大行评级 | 花旗看高AMD至800美元！富国上调Meta目标价至1000美元
今日重点评级关注：Jones Trading：维持Opus Genetics"买入"评级，目标价从10美元升至17美元；Citizens：维持Rezolute"跑赢大市"评级，目标价从11美元升至15美元
10-07 17:30
TD Cowen Maintains Buy on Upbound Group, Lowers Price Target to $27
TD Cowen analyst Moshe Orenbuch maintains Upbound Group (NASDAQ:UPBD) with a Buy and lowers the price target from $28 to $27.
10-06 23:03
Upbound Group declares $0.39 dividend
Upbound Group (UPBD) declares $0.39/share quarterly dividend, in line with previous. Forward yield 9.76% Payable Oct. 27; for shareholders of record Oct. 6; ex-div Oct. 6. See UPBD Dividend Scorecard,...
09-24 20:02
Upbound Group Names New COO to Drive Integration
Upbound Group ( ($UPBD) ) has issued an update. On September 22, 2026, Upbound ...
09-22 21:33
